October 2024

SAN DIEGO, Oct. 15, 2024 /PRNewswire/ — Kintara Therapeutics, Inc. (“Kintara”) (NASDAQ: KTRA), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced a correction to the press release previously issued by Kintara on October 14,

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: